TGTX — TG Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for TG Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	140	605	315	162	218
Net Total Accounts Receivable
Net Total Receivables	—	—	1.39	0	51.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	149	612	331	168	318
Net Property, Plant And Equipment	11.8	11.8	11.1	10.8	9.56
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets	163	626	380	194	330
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	84.4	87.6	65.4	53.2	53.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	124	106	142	135	169
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	38.6	519	237	58.6	161
Total Liabilities & Shareholders' Equity	163	626	380	194	330
Total Common Shares Outstanding
Total Preferred Shares Outstanding